These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22901586)

  • 1. Extended followup oncologic outcome of randomized trial between cryoablation and external beam therapy for locally advanced prostate cancer (T2c-T3b).
    Chin JL; Al-Zahrani AA; Autran-Gomez AM; Williams AK; Bauman G
    J Urol; 2012 Oct; 188(4):1170-5. PubMed ID: 22901586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer.
    Chin JL; Ng CK; Touma NJ; Pus NJ; Hardie R; Abdelhady M; Rodrigues G; Radwan J; Venkatesan V; Moussa M; Downey DB; Bauman G
    Prostate Cancer Prostatic Dis; 2008; 11(1):40-5. PubMed ID: 17579613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer.
    Donnelly BJ; Saliken JC; Brasher PM; Ernst SD; Rewcastle JC; Lau H; Robinson J; Trpkov K
    Cancer; 2010 Jan; 116(2):323-30. PubMed ID: 19937954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
    Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
    Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer: quality of life outcomes.
    Robinson JW; Donnelly BJ; Siever JE; Saliken JC; Ernst SD; Rewcastle JC; Trpkov K; Lau H; Scott C; Thomas B
    Cancer; 2009 Oct; 115(20):4695-704. PubMed ID: 19691092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to achieve a PSA level Mitchell DM; McAleese J; Park RM; Stewart DP; Stranex S; Eakin RL; Houston RF; O'Sullivan JM
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1467-71. PubMed ID: 17689886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
    Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
    J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy.
    Zelefsky MJ; Marion C; Fuks Z; Leibel SA
    J Urol; 2003 Nov; 170(5):1828-32. PubMed ID: 14532785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cryoablation nadir prostate specific antigen and biochemical failure.
    Levy DA; Pisters LL; Jones JS
    J Urol; 2009 Sep; 182(3):931-7. PubMed ID: 19616226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation.
    Rosser CJ; Chichakli R; Levy LB; Kuban DA; Smith LG; Pisters LL
    J Urol; 2002 Aug; 168(2):536-41. PubMed ID: 12131304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
    Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
    Wong WW; Schild SE; Vora SA; Halyard MY
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):24-9. PubMed ID: 15337536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer.
    Crook J; Ludgate C; Malone S; Lim J; Perry G; Eapen L; Bowen J; Robertson S; Lockwood G
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):15-23. PubMed ID: 15337535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate.
    Rosser CJ; Levy LB; Kuban DA; Chichakli R; Pollack A; Lee A; Pisters LL
    J Urol; 2003 Jun; 169(6):2160-5. PubMed ID: 12771739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy.
    de Castro Abreu AL; Bahn D; Leslie S; Shoji S; Silverman P; Desai MM; Gill IS; Ukimura O
    BJU Int; 2013 Aug; 112(3):298-307. PubMed ID: 23826840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment.
    Stromberg JS; Martinez AA; Horwitz EM; Gustafson GS; Gonzalez JA; Spencer WF; Brabbins DS; Dmuchowski CF; Hollander JB; Vicini FA
    Cancer J Sci Am; 1997; 3(6):346-52. PubMed ID: 9403047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage prostate cryoablation: initial results from the cryo on-line data registry.
    Pisters LL; Rewcastle JC; Donnelly BJ; Lugnani FM; Katz AE; Jones JS
    J Urol; 2008 Aug; 180(2):559-63; discussion 563-4. PubMed ID: 18554664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma.
    Algan O; Fosmire H; Hynynen K; Dalkin B; Cui H; Drach G; Stea B; Cassady JR
    Cancer; 2000 Jul; 89(2):399-403. PubMed ID: 10918172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.